Share Name Share Symbol Market Type
RELX Plc EU:REN Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.29 -1.07% 26.82 26.35 27.50 26.98 26.62 26.76 1,405,567 16:40:00

RELX's Nine-Month Events Revenue Fell 70%

22/10/2020 7:50am

Dow Jones News

Historical Stock Chart

From Jan 2020 to Jan 2022

Click Here for more RELX Charts.
   By Adria Calatayud 

RELX PLC said Thursday that revenue from its exhibitions business fell 70% for the first nine months of the year, but that its three largest business areas continued to gradually improve during the third quarter.

The FTSE 100 information and analytics group said it now expects exhibitions revenue for the full year to be between 330 million and 360 million pounds ($433.9 million-$473.3 million), and costs for the unit to be between GBP530 million and GBP540 million excluding one-off costs related to restructuring and cancellations.

The company behind the Lancet medical journal and the London Book Fair said the outlook for its three largest businesses--scientific, technical and medical, risk and business-analytics, and legal--remains unchanged.

For the first nine months of the year, underlying revenue rose 2% at RELX's scientific, technical and medical business, 3% at its risk and business-analytics unit and 1% at its legal division.


Write to Adria Calatayud at adria.calatayud@dowjones.com


(END) Dow Jones Newswires

October 22, 2020 02:35 ET (06:35 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year RELX Chart

1 Year RELX Chart

1 Month RELX Chart

1 Month RELX Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220129 07:17:23